235 related articles for article (PubMed ID: 16636053)
21. Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.
Dang Y; Wang X; York IA; Zheng YH
J Virol; 2010 Sep; 84(17):8561-70. PubMed ID: 20592083
[TBL] [Abstract][Full Text] [Related]
22. Comparative thermodynamic analysis of zinc binding to the His/Cys motif in virion infectivity factor.
Ghimire-Rijal S; Maynard EL
Inorg Chem; 2014 May; 53(9):4295-302. PubMed ID: 24735396
[TBL] [Abstract][Full Text] [Related]
23. Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.
Dang Y; Davis RW; York IA; Zheng YH
J Virol; 2010 Jun; 84(11):5741-50. PubMed ID: 20335268
[TBL] [Abstract][Full Text] [Related]
24. Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins.
Zhang W; Wang H; Li Z; Liu X; Liu G; Harris RS; Yu XF
J Virol; 2014 Nov; 88(21):12528-40. PubMed ID: 25142583
[TBL] [Abstract][Full Text] [Related]
25. Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.
Fribourgh JL; Nguyen HC; Wolfe LS; Dewitt DC; Zhang W; Yu XF; Rhoades E; Xiong Y
J Virol; 2014 Mar; 88(6):3309-19. PubMed ID: 24390320
[TBL] [Abstract][Full Text] [Related]
26. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.
Jäger S; Kim DY; Hultquist JF; Shindo K; LaRue RS; Kwon E; Li M; Anderson BD; Yen L; Stanley D; Mahon C; Kane J; Franks-Skiba K; Cimermancic P; Burlingame A; Sali A; Craik CS; Harris RS; Gross JD; Krogan NJ
Nature; 2011 Dec; 481(7381):371-5. PubMed ID: 22190037
[TBL] [Abstract][Full Text] [Related]
27. Structural analysis of viral infectivity factor of HIV type 1 and its interaction with A3G, EloC and EloB.
da Costa KS; Leal E; dos Santos AM; Lima e Lima AH; Alves CN; Lameira J
PLoS One; 2014; 9(2):e89116. PubMed ID: 24586532
[TBL] [Abstract][Full Text] [Related]
28. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.
Yu X; Yu Y; Liu B; Luo K; Kong W; Mao P; Yu XF
Science; 2003 Nov; 302(5647):1056-60. PubMed ID: 14564014
[TBL] [Abstract][Full Text] [Related]
29. Requirement of HIV-1 Vif C-terminus for Vif-CBF-β interaction and assembly of CUL5-containing E3 ligase.
Wang H; Lv G; Zhou X; Li Z; Liu X; Yu XF; Zhang W
BMC Microbiol; 2014 Nov; 14():290. PubMed ID: 25424878
[TBL] [Abstract][Full Text] [Related]
30. Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif.
Guo Y; Dong L; Qiu X; Wang Y; Zhang B; Liu H; Yu Y; Zang Y; Yang M; Huang Z
Nature; 2014 Jan; 505(7482):229-33. PubMed ID: 24402281
[TBL] [Abstract][Full Text] [Related]
31. Effect of HIV-1 Vif variability on progression to pediatric AIDS and its association with APOBEC3G and CUL5 polymorphisms.
De Maio FA; Rocco CA; Aulicino PC; Bologna R; Mangano A; Sen L
Infect Genet Evol; 2011 Aug; 11(6):1256-62. PubMed ID: 21571098
[TBL] [Abstract][Full Text] [Related]
32. Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G.
Xiao Z; Ehrlich E; Luo K; Xiong Y; Yu XF
FASEB J; 2007 Jan; 21(1):217-22. PubMed ID: 17135358
[TBL] [Abstract][Full Text] [Related]
33. Advances in the structural understanding of Vif proteins.
Barraud P; Paillart JC; Marquet R; Tisné C
Curr HIV Res; 2008 Mar; 6(2):91-9. PubMed ID: 18336256
[TBL] [Abstract][Full Text] [Related]
34. The assembly of Vif ubiquitin E3 ligase for APOBEC3 degradation.
Kim DY
Arch Pharm Res; 2015 Apr; 38(4):435-45. PubMed ID: 25408426
[TBL] [Abstract][Full Text] [Related]
35. Insight into the HIV-1 Vif SOCS-box-ElonginBC interaction.
Lu Z; Bergeron JR; Atkinson RA; Schaller T; Veselkov DA; Oregioni A; Yang Y; Matthews SJ; Malim MH; Sanderson MR
Open Biol; 2013 Nov; 3(11):130100. PubMed ID: 24225024
[TBL] [Abstract][Full Text] [Related]
36. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
37. Conformational analysis of a peptide approximating the HCCH motif in HIV-1 Vif.
Giri K; Maynard EL
Biopolymers; 2009; 92(5):417-25. PubMed ID: 19382167
[TBL] [Abstract][Full Text] [Related]
38. Both Rbx1 and Rbx2 exhibit a functional role in the HIV-1 Vif-Cullin5 E3 ligase complex in vitro.
Wang X; Wang X; Wang W; Zhang J; Wang J; Wang C; Lv M; Zuo T; Liu D; Zhang H; Wu J; Yu B; Kong W; Wu H; Yu X
Biochem Biophys Res Commun; 2015 Jun; 461(4):624-9. PubMed ID: 25912140
[TBL] [Abstract][Full Text] [Related]
39. A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G.
Chen G; He Z; Wang T; Xu R; Yu XF
J Virol; 2009 Sep; 83(17):8674-82. PubMed ID: 19535450
[TBL] [Abstract][Full Text] [Related]
40. Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases.
Zhang W; Huang M; Wang T; Tan L; Tian C; Yu X; Kong W; Yu XF
Cell Microbiol; 2008 Aug; 10(8):1662-75. PubMed ID: 18419775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
